HYPERadrenocorticism Flashcards

1
Q

Adrenal Gland Physiology

Medulla

A

central core

a sympathetic ganglion that has lost its axon

Produces norepinephrine, epinephrine and dopamine

Composes 28% of the entire adrenal mass

Cat - secretes primarily norepinephrine: Dog - Primarily Epinephrine

Actions of Hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Adrenal Gland Physiology

Cortex

Zona Glomerulosa

A

outer most layer

mineralocorticoids - aldosterone

the cells of this layer can regenerate the other two layers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Adrenal Gland Physiology

Cortex

Zona Fasciculata

A

Glucocorticoids - cortisol

Largest of the 3 zones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Adrenal Gland Physiology

Cortex

Zona Reticularis

A

inner most layer

Sex steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adrenal Gland Physiology

Hormone Production

A

All hormones of the adrenal cortex are derivatives of cholesterol

Cholesterole ester hydrolase liberates cholesterol

Cholesterol transported to the mitochondria and converted by cholesterol desmolase to pregenolone

Pregenolone is transported to the SER, converted to progesterone and 17-hydroxyprenenolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adrenal Gland Physiology

Hormone Release

Corticotropin-Releasing Hormone

A

Released by hypothalamus

Provides control over secretion of adrenocorticotropin hormone release from pituitary

CRH - release influenced by

set-point/basal release

diurnal rhythms

Input from nociceptive pathways

Input from limbic system during stress

Hypoglycemia

Cortisol-negative feed back on release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Adrenal Gland Physiology

Hormone release

Adrenocorticotropic Hormone (ACTH)

A

Produced from corticotrophs in the pituitary gland

ACTH serum half life : 10 minutes

Function: Stimulate cortisol release from adrenal cortex,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Adrenal Gland Physiology

Glucocorticoids

A

Cortisol - Zona fasciculata but also zona reticularis

Physiological effects

Metabolism

Gluconeogenesis/glycogeneisis

protein catabolism

Lipolysis

Antagonizes the effect of insulin

Anti-inflammatory / immunosuppressive effects

Modulate function of many cells: bone marrow, GI mucosal barriers, Renal calcium excretion, others

Regulation of Cortisol Secretion:

CRH and ACTH secreted in a pulatile manner

ACTH secretion increases in response to feeding:

Stress

pain

trauma

pyrogens

cold exposure

Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Adrenal Gland Physiology

Mineralocorticoids

A
  • Aldosterone - Zona glomerulosa
  • Physiologic effect: sodium, potassium, and water homeostasis
  • Regulation of aldosterone secretion:
    • Primary controls:
      • Serum potassium levels
      • Renin-angiotensin system
    • Other control
      • ACTH minimal role
      • Response is blunted by 1-2 days with chronic ACTH elevation
      • Sodium
      • Must be a drop in sodium
      • Atrial natriuretic peptide
      • Decreases renin secretion to decrease AT II levels
        • Decreased responsiveness of adrenal to ATII
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hyperadrenocorticisms

A

Abnormalitites, both clinical and chemical, that results from excessive, chornic exposure to glucocorticoids regardless of etiology

Pituitary - excess ACTH due to pituitary tumor

Adrenal-autonomous cortisol secretion due to adrenocortical carcinoma or adenoma

Hypothalamic - pituiary hyperplasia due to ecess corticotropic-releasing hormone

Iatrogenic - excess glucocorticoid administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cushing disease

A

HAC due to an ACTH producing pitutiary tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cushing Syndrome

A

Clinicla signs due to glucocorticoid excess from any cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Canine Hyperadrenocorticism

Pituitary Dependent Hyperadrenocorticism

A

Most common ~85% of cases

Excess adrenocorticotropic hormone (ACTH) production bu the pars distalis of hte pituitary gland

Microadenoma: <1cm in diameter

Signs due to excessive ACTH and subsequent excessive cortisol production, with a loss of negative feedback

Macroadenoma: up to 15%, >1cm in diameter

Signs due to excessive ACTH and subsequent excessive cortisol production

Bilateral adrenal hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Canine Hyperadrenocorticism

Adrenal Dependent Hyperadrenocorticism (ADH)

A

Less common: 15% of all cases

Autonomous production of cortisol

Adenoma ~50% benign

Carcinoma ~50% malignant, local extension, metastasis to liver and lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Canine Hyperadrenocorticism

Signalment

Age

A

middle-aged to older

rare for HAC to occur in any dog <6yrs

Dogs with ADH are usually older than dogs with PDH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Canine Hyperadrenocorticsm

signalment

Sex

A

Females slightly overrepresented

Accountif for 55-60% of dogs with PDH

account for 60-65% of dogs with ADH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Canine Hyperadrenocortisms

Signalment

Breed

A

PDH: smaller preed dogs more common

ADH: ~50% >20kg, rest small breed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Canine Hyperadrenocorticism

Clinical Signs

Polydipsia and Polyuria

A

85-97% of dogs with HAC

Glucocorticoids interfere with antidiuretic hormone release and activity, resulting in polyuria

Polydipsia is compensatory

Normal water consumption

Polydipsia >100ml/kg/d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Canine Hyperadreonocorticism

Clinical signs

Polyphagia

A

Occurs in most dogs with HAC

Glucocorticoids have direct stimulatory effect on the appetite

Ravenous appetite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Canine Hyperadreonocorticism

Clinical signs

Pendulous Abdomen

A

>80% of dogs with HAC

Due to: Redistribution of fat to the abdomen

muscle wasting of the abdominal muscles

Hepatomegaly

Often misinterpreted was weight gain by the owner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Canine Hyperadreonocorticism

Clinical signs

Panting

A

Wasting of muscle of respiration

Reduced capability of thoracic expansion from the distended abdomen

muscle weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Canine Hyperadreonocorticism

Clinical signs

Infections

A

Urinary tract infections

Pyoderma, respiratory, oral cavity

Unusual organisms causing infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Canine Hyperadreonocorticism

Clinical signs

Muscle weakness / loss

A

excessive protien catabolism and muscle wasting

24
Q

Canine Hyperadreonocorticism

Clinical signs

Dermatologic Changes

A

Bilateral changes

Symmetrical truncal alopecia and thin skin

Hyperpigmentation and comedones

calcinosis cutis

Bruising

Poor wound healing

Pyoderma

25
Canine Hyperadreonocorticism Clinical signs Cardiovascular effects
sodium and water retention results in hypertension and hypervolemia
26
Canine Hyperadreonocorticism Clinical signs Neurologic signs
Anorexia, behavioral changes, and disorientation, circling, central blindness, or other neurologic signs 10-15% of dogs with PDH in association with a macroademona
27
Canine Hyperadreonocorticism Clinical signs Repro
Negative feedback on pituitary gonadotropin secretions Decrease in testicular androgen production in males Anestrus in females
28
Canine Hyperadreonocorticism Clinical signs Others
Myotonia facial nerve paralysis Diabetes mellitus Proteinuria / hypoalbuminemia Pulmonary thromboemboli Hypercoagulable state
29
Canine Hyperadrenocorticism Diagnosis
Can be a diagnostic delimma because no test is highly sensitive or specific Cortisol cna be elevated due to non-adrenal illness Clinical signs compatible but diagnostics don't support clinical suspicion Other steroid production causing clinical signs
30
Canine Hyperadrenocorticism Diagnosis Minimum Data Base
* CBC * stess leukogram * Thromobocytosis * Chemistry * Elevated liver enzymes (ALP\>ALT) * ALP: * Primarily due to the GC-induced isoenzyme * Secondary to mild intrahepatic cholestasis from glycogen deposistion * ALT: * variable mild hepatic necrosis, glycogen storage, swollen hepatocytes * Hypercholestrolemia * due to stimulated lipolysis * Hyperglycemia * Urinalysis * always perform with HAC regardless of urine sediment * Blood Pressure * hypertensive * Radiographs * Hepatomegaly, ectopic clacification, Adrenal tumor, Osteoporosis, Cystic Calculi
31
Canine Hyperadrenocorticism HAC Testing
Two step process * Screening: * Confirms clinical suspicion of HAC * Differentiating Test * Choose appropriate treatment plan * Medical - Pituitary dependent * Surgical - adrenal dependent
32
Canine Hyperadrenocorticism HAC Testing Screening Test
THere is NO Perfect test A postive test result should never be the sole basis of your diagnosis Adrenocorticotropic hormone stimulation test Low Dose Dexamethasone Suppression test Urine Cortisol:Creatinine ratio
33
Canine Hyperadrenocorticism HAC Testing Screening Test ACTH Stimulation Test
Sensitivity - PDH Specificity - PDH and ADH Chronic stress or non-adrenal illness may produce test results suggestive of HAC Advantages: Fast - 1 hour to preform good choice if non-adrenal illness is suspected ONLY WAY TO DIAGNOSE IATROGENIC HAC Disadvantages - EXPENSIVE
34
Canine Hyperadrenocorticism HAC Testing Screening Test Low Dose Dexamethasone Suppresion Test
Procedure: baseline cortisol; injection dexamethasone IV, Collect serum samples 4 hrs and 8 hrs post injection Interpretation: Normal - suppressio of plasma cortisol at 4 and 8 hrs HAC - no suppression at 4 or 8 hrs PDH - may exhibit suppression form baseline cortisol May exibit normal suppression at 4 hrs but escape into anbormal range at 8 hrs
35
Canine Hyperadrenocorticism HAC Testing Screening Test Low Dose Dexamethasone Suppresion Test Advantages
Good choice for non-adrenal illness is not suspected Is a differentiating test if suppression followed by escape Inexpensive
36
Canine Hyperadrenocorticism HAC Testing Screening Test Low Dose Dexamethasone Suppresion Test Disadvantage
Takes 8 hours to perform
37
Canine Hyperadrenocorticism HAC Testing Screening Test Urine Cortisol: Creatinine Ratio
Best used to determine if a dog does NOT have HAC Sensitivity - nearly 100% Consistently high serum cortisol results in proportionately high amount excreted in the urine Negative Results rules out HAC
38
Canine Hyperadrenocorticism Differentiating Test Goal
differentiate pituitary dependent vs. adrenal dependent hyperadrenocorticsm Abdominal ultrasound high dose dexamethasone suppression test endogenous ACTH meausurement
39
Canine hyperadrenocorticism Differential tests Abdominal ultrasound PDH
bilateral adrenal hypertrophy overlap in normal adrenal gland size and hypertrophy Threshold of 7.4mm diameter = 77% sensitivity and 80-91% specificity
40
Canine hyperadrenocorticism Differential tests Abdominal ultrasound ADH
Unilateral adrenal enlargement, contralateral atrophy Presence does not equal functional adrenal mass
41
Canine hyperadrenocorticism Differential tests HIgh Dose Dexamethasone Suppression Test (HDDST)
Procedure - same as LDDST except use 0.1mg/kg ADH - do not suppress at 4 or 8 hours PDH - will suppress at 4 or 8 hours Failure to suppress means the odds of having PDH vs. ADH is 50-50 because ADH never suppress but PDH is the most common form
42
Canine hyperadrenocorticism Differential tests Endogenous ACTH levels
Not used clinically Advantages - can positively differentiate PDH vs. ADH Diasadvantages - difficult to measure
43
Canine hyperadrenocorticism Differential tests Computed Tomography (CT)
diagnosis of adrenal tumors pituitary tumors when macroadenoma present
44
Canine hyperadrenocorticism Differential tests Magnetic Resonance Imaging (MRI)
more accurate for visualization of small pituitary tumors but only 50% of dogs with PDH will have identifiable microadenoma
45
Pituitary Dependnet HAC Medical Management
TREATMENT OF CHOICE Necrosis of adrenal cortex - fasiculata and reticularis most susceptibel Enzyme inhibitors in steroid synthesis pathways trilostane ketoconazole L-Deprenyl
46
Pituitary Dependent HAC Trilostane
FDA approved for dogs - therapy of choice in US Competitive inhibitor of 3B hydroxysteroid dehydrogenase → inhibits production of progesterone and 17-hydroxyprogesterono → inhibits adrenal cortisol and aldosterone
47
Pituitary Dependent HAC Trilostane Efficacy
sings improve within a few weeks of starting drug. Marked improvement within 2 months. enzyme inhibition rapidly reversible if dugs is discontinued
48
Pituitary Dependent HAC Trilostane Adverse Effects
transient vomiting, diarrhea, lethargy rarely, hypoadrenocorticism may develop Adrenal necrosis causing death is a rarely reported adverse effect
49
Pituitary Dependent HAC Trilostane Monitoring therapy
There is no single protocol shown to be superior to another ACTH stimulation test is recommended on the trilostane insert. 10-14 days after starting trilostane 2 weeks after dose increase every 3 months for the long term
50
Adrenal Dependent HAC Surgical Treatment
TREATMENT OF CHOICE unilateral adrenalectomy if metastatic disease and invasion absent of adjacent structures is absent
51
Adrenal Dependent HAC Surgery Complications
Perioperative complications: hemorrhage, pulmonary thromboembolism Post-Operative complications: acute adrenal insufficiency, organ fialure/vascular
52
Adrenal Dependent HAC Surgery Prognosis
MST 36 month if benign and easily removed and the patient survives the first two weeks Malignant tumors have less favorable prognosis
53
Adrenal Dependent HAC Medical Options
Mitotane: necrosis of adrenal cortex, may also have effects on metastatic lesions, often requires longer induction phase and higher dose for maintenance pase Trilostane: no efficacy reported
54
HAC prognosis PDH
most treated dogs experience imporved quality of life and show a reduction in clinical signs, reduced morbidity, and alleviation of long-term complications associated with untreated disease Persistence or development of CNS signs carries a guarded to poor prognosis without intervention to address pituitary enlargement
55
HAV prognosis ADH
benign adrenal tumors carry a good/excellent prognosis after successful removal. Malignant tumors have a guarded to grave prognosis